| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/08/2003 | EP1272505A1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 01/08/2003 | EP1272504A1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/08/2003 | EP1272499A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/08/2003 | EP1272488A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 01/08/2003 | EP1272487A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272481A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
| 01/08/2003 | EP1272457A2 Compounds for modulating cell proliferation |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272236A1 Methods and compositions for treating intervertebral disc degeneration |
| 01/08/2003 | EP1272232A1 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material |
| 01/08/2003 | EP1272230A1 An injectable bone mineral substitute material |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272200A1 Divided dose therapies with vascular damaging activity |
| 01/08/2003 | EP1272191A2 An efficacious dosage regimen of galantamine that reduces side effects |
| 01/08/2003 | EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272172A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1077945B1 Isoquinolines as urokinase inhibitors |
| 01/08/2003 | EP0983294B1 B-ring estratriene diol sulphates |
| 01/08/2003 | EP0859622B1 Extracts of shark cartilage |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 01/08/2003 | CN1390200A Inhibitors of metalloproteinases |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390130A Glucosamine and egg for reducing inflammation |
| 01/08/2003 | CN1389260A Medicated bag for flexibilizing tendons, setting fracture and relieving pain and its prepn. process |
| 01/08/2003 | CN1389256A Chinese medicine for treating cervical spondylosis |
| 01/08/2003 | CN1389255A Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis |
| 01/08/2003 | CN1389254A Composite Chinese medicine for treating protrusion of lumber interverterbral disc |
| 01/08/2003 | CN1389252A Composite medicine for treating femoral head necrosis |
| 01/08/2003 | CN1389246A Medicine tablet for eliminating bone pain and its prepn. |
| 01/08/2003 | CN1389245A Composite Chinese medicine for treating atrophy and flaccid paralysis of legs |
| 01/08/2003 | CN1389210A Application of sophoricoside |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098079C Medicinal liquid for treating ligagmentum sacrotuberosum disease |
| 01/07/2003 | US6503934 Substituted thiadiazolesulfonamides |
| 01/07/2003 | US6503931 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503914 Thienopyrimidine-based inhibitors of the Src family |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503542 Herbal compositions for treating immunological disorders |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/05/2003 | CA2392189A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2387981A1 Pharmaceutical composition |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000682A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/03/2003 | WO2003000678A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000287A1 Remedies for hernia |
| 01/03/2003 | WO2003000270A1 Novel pyridopyrimidones and uses thereof |
| 01/03/2003 | WO2003000257A1 TGF-ß SUPERFAMILY PRODUCTION/SECRETION PROMOTER |
| 01/03/2003 | WO2003000194A2 Thienopyridine and thienopyrimidine anticancer agents |
| 01/03/2003 | WO2003000191A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 01/03/2003 | WO2003000190A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 01/03/2003 | WO2003000187A2 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000183A2 Method of treating atherosclerosis and other inflammatory diseases |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000056A1 Joint lubrication with p2y purinergic receptor agonists |
| 01/03/2003 | WO2003000011A2 Novel pyridopyrimidines and uses thereof |
| 01/03/2003 | WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002080914A3 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments |
| 01/03/2003 | WO2002047673A3 Methods and compositions to treat conditions associated with neovascularization |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002045754A3 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 01/03/2003 | WO2002045702A3 Tricyclic therapeutics for chemokine mediated diseases |
| 01/03/2003 | WO2002043653A3 Crystalline glucosamine sulphate metal salts |
| 01/03/2003 | WO2002034741A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 01/03/2003 | WO2002016557A3 Tissue engineering scaffolds promoting matrix protein production |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002003976A3 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2001044260A8 Novel purines |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451625A1 Substituted n-acyl-aniline derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |